Partnership combines FITI's global manufacturing capabilities and precision expertise with TAE Life Sciences’ in-house systems integration and installation expertise

TAE Life Sciences ("TAELS") today announced a new contract manufacturing agreement with Foxsemicon Integrated Technology, Inc. ("FITI"), a global vertically integrated high-end equipment manufacturer, headquartered in Taiwan. Under the agreement, FITI will provide component fabrication, board- and system-level assembly, and testing services in support of TAELS’s Alphabeam™ BNCT technology platforms.

FITI was selected as TAELS's manufacturing partner based on several key factors:

• Proven scale and reliability. FITI has a long track record supporting some of the world's largest technology companies, giving TAELS confidence in its ability to deliver consistent quality at volume.
• Relevant technical expertise. FITI has 25 years of expertise in high-end equipment manufacturing, including semiconductor process equipment and medical equipment with comprehensive mechanical, optical, electrical, radio frequency (RF), and software technologies — capabilities directly relevant to TAELS’s systems.
• Quality certification. FITI operates an ISO 13485-certified manufacturing facility, reflecting a quality management system built around rigorous process control, traceability, and documentation.

While FITI will manufacture and test components and subsystems under the agreement, TAELS will continue to perform final system assembly, integration, and installation directly at customers’ facilities worldwide. This structure allows TAE to draw on FITI's manufacturing capacity and specialized expertise for upstream production while retaining direct, in-house control over the final assembly, quality verification, and on-site installation of its systems.

“This partnership with FITI strengthens our manufacturing supply chain at a critical point in our growth where scalability is going to be a key factor in our success. FITI's experience with high-end equipment manufacturing, including semiconductor process equipment and medical equipment with comprehensive mechanical, optical, electrical, radio frequency (RF), and software technologies means we're working with a partner who understands the precision our technology demands. This partnership is about scaling our capacity without compromising the quality and control we require,” said Rob Hill, CEO, TAE Life Sciences.

“We're proud to support TAE Life Sciences as its contract manufacturing partner,” said Charles Hsu, VP of Foxsemicon Integrated Technology. “TAE Life Sciences’ systems require high-end equipment manufacturing capabilities and rigorous quality standards. FITI’s manufacturing expertise and ISO 13485-certified facility position as well to support these requirements. We look forward to building a long-term collaboration that helps TAE scale efficiently.”

About TAE Life Sciences

TAE Life Sciences is pioneering next-generation Boron Neutron Capture Therapy (BNCT) with a pipeline of proprietary boron drugs and accelerator-based neutron systems, advancing precision radiation therapy and combination regimens to improve survival for patients with hard-to-treat cancers.

About Foxsemicon Integrated Technology, Inc. (FITI)

Founded in 2001, FITI is a Taiwan-listed global advanced equipment manufacturer. With 25 years of manufacturing experience, FITI provides advanced, vertically integrated manufacturing capabilities for semiconductor, medical, and other high-end technology equipment through its production facilities and service centers worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260922323822/en/